Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperaldosteronism | 75 | 2024 | 247 | 17.340 |
Why?
|
Adrenalectomy | 45 | 2024 | 346 | 5.730 |
Why?
|
Aldosterone | 44 | 2024 | 870 | 4.660 |
Why?
|
Adrenocortical Adenoma | 12 | 2023 | 46 | 3.700 |
Why?
|
Adrenal Glands | 17 | 2024 | 552 | 2.030 |
Why?
|
Adrenal Cortex Neoplasms | 7 | 2021 | 161 | 2.000 |
Why?
|
Hypertension | 30 | 2024 | 8540 | 1.890 |
Why?
|
Renal Dialysis | 9 | 2024 | 1796 | 1.520 |
Why?
|
Acute Kidney Injury | 13 | 2024 | 1924 | 1.350 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 8 | 2023 | 61 | 1.070 |
Why?
|
Adrenal Gland Neoplasms | 6 | 2023 | 732 | 1.070 |
Why?
|
Adenoma | 9 | 2023 | 2163 | 1.000 |
Why?
|
Taiwan | 21 | 2023 | 521 | 0.990 |
Why?
|
Hydrocortisone | 10 | 2023 | 1819 | 0.960 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 107 | 0.840 |
Why?
|
Diabetic Nephropathies | 3 | 2024 | 973 | 0.800 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15502 | 0.750 |
Why?
|
Interleukin-18 | 1 | 2022 | 250 | 0.740 |
Why?
|
Renin | 10 | 2024 | 641 | 0.640 |
Why?
|
Cushing Syndrome | 1 | 2020 | 241 | 0.630 |
Why?
|
Otoscopy | 1 | 2018 | 40 | 0.600 |
Why?
|
Diastole | 3 | 2020 | 782 | 0.580 |
Why?
|
Embolization, Therapeutic | 3 | 2021 | 1418 | 0.540 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2242 | 0.530 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 12149 | 0.530 |
Why?
|
Ear Diseases | 1 | 2018 | 180 | 0.520 |
Why?
|
Creatinine | 6 | 2023 | 1899 | 0.500 |
Why?
|
Glomerular Filtration Rate | 8 | 2024 | 2178 | 0.500 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2014 | 69 | 0.480 |
Why?
|
Salvage Therapy | 1 | 2021 | 1263 | 0.460 |
Why?
|
Databases, Factual | 6 | 2024 | 7968 | 0.450 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2020 | 2118 | 0.440 |
Why?
|
Hemofiltration | 1 | 2013 | 59 | 0.420 |
Why?
|
Uremia | 1 | 2013 | 201 | 0.400 |
Why?
|
Liver Transplantation | 1 | 2023 | 2330 | 0.390 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3085 | 0.380 |
Why?
|
Humans | 107 | 2024 | 761596 | 0.370 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2016 | 1050 | 0.370 |
Why?
|
Intracranial Pressure | 1 | 2013 | 324 | 0.370 |
Why?
|
Liver Neoplasms | 3 | 2021 | 4317 | 0.360 |
Why?
|
Otolaryngology | 1 | 2018 | 693 | 0.360 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2226 | 0.350 |
Why?
|
Middle Aged | 53 | 2024 | 220921 | 0.340 |
Why?
|
Treatment Outcome | 26 | 2024 | 64685 | 0.330 |
Why?
|
Education, Medical, Undergraduate | 1 | 2018 | 1070 | 0.310 |
Why?
|
Renal Replacement Therapy | 3 | 2021 | 282 | 0.310 |
Why?
|
Retrospective Studies | 34 | 2024 | 80647 | 0.300 |
Why?
|
Male | 57 | 2024 | 360846 | 0.290 |
Why?
|
Kidney Failure, Chronic | 6 | 2020 | 2472 | 0.270 |
Why?
|
Adult | 42 | 2024 | 221210 | 0.270 |
Why?
|
Female | 55 | 2024 | 392705 | 0.260 |
Why?
|
Mitral Valve | 1 | 2014 | 1465 | 0.260 |
Why?
|
Steroid 11-beta-Hydroxylase | 2 | 2022 | 20 | 0.250 |
Why?
|
Ventricular Remodeling | 4 | 2023 | 1267 | 0.250 |
Why?
|
Ventricular Function, Left | 2 | 2016 | 3879 | 0.250 |
Why?
|
Aged | 35 | 2024 | 169310 | 0.240 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2023 | 851 | 0.210 |
Why?
|
Captopril | 2 | 2023 | 265 | 0.210 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 72 | 0.210 |
Why?
|
Hemodynamics | 1 | 2013 | 4160 | 0.210 |
Why?
|
Calcium Channels, T-Type | 1 | 2022 | 28 | 0.210 |
Why?
|
Adosterol | 2 | 2023 | 6 | 0.200 |
Why?
|
Risk Factors | 15 | 2024 | 74213 | 0.200 |
Why?
|
Clinical Competence | 1 | 2018 | 4793 | 0.200 |
Why?
|
Prospective Studies | 14 | 2024 | 54423 | 0.200 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2656 | 0.190 |
Why?
|
Hyperuricemia | 1 | 2024 | 222 | 0.190 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3359 | 0.190 |
Why?
|
Renal Insufficiency | 2 | 2022 | 809 | 0.190 |
Why?
|
Antihypertensive Agents | 5 | 2023 | 2024 | 0.190 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4062 | 0.180 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6938 | 0.180 |
Why?
|
Echocardiography | 6 | 2023 | 4989 | 0.180 |
Why?
|
Time Factors | 9 | 2024 | 39969 | 0.180 |
Why?
|
Cohort Studies | 8 | 2024 | 41495 | 0.180 |
Why?
|
Risk Assessment | 10 | 2024 | 23996 | 0.180 |
Why?
|
Spironolactone | 2 | 2021 | 412 | 0.180 |
Why?
|
Mitochondria, Heart | 1 | 2021 | 229 | 0.170 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2019 | 12 | 0.170 |
Why?
|
Radiopharmaceuticals | 2 | 2020 | 2650 | 0.170 |
Why?
|
Radiation Pneumonitis | 1 | 2020 | 102 | 0.170 |
Why?
|
Blood Specimen Collection | 3 | 2021 | 238 | 0.170 |
Why?
|
Hearing Aids | 1 | 2020 | 58 | 0.170 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1241 | 0.160 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2024 | 1875 | 0.160 |
Why?
|
Pericardium | 1 | 2023 | 675 | 0.160 |
Why?
|
Brachial Artery | 1 | 2020 | 366 | 0.160 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 374 | 0.150 |
Why?
|
Uric Acid | 1 | 2024 | 807 | 0.150 |
Why?
|
Specimen Handling | 2 | 2020 | 702 | 0.150 |
Why?
|
Ankle Brachial Index | 3 | 2024 | 163 | 0.150 |
Why?
|
Aftercare | 1 | 2024 | 914 | 0.150 |
Why?
|
Prevalence | 7 | 2024 | 15733 | 0.150 |
Why?
|
Echocardiography, Transesophageal | 1 | 2023 | 1086 | 0.140 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2020 | 2297 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1739 | 0.140 |
Why?
|
Patient Positioning | 1 | 2019 | 326 | 0.140 |
Why?
|
GPI-Linked Proteins | 1 | 2018 | 470 | 0.130 |
Why?
|
Health Status Indicators | 2 | 2012 | 970 | 0.130 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 865 | 0.130 |
Why?
|
Cause of Death | 2 | 2024 | 3683 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1844 | 0.130 |
Why?
|
Angiography | 1 | 2020 | 1595 | 0.120 |
Why?
|
Cardiomegaly | 1 | 2018 | 590 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2021 | 683 | 0.120 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 532 | 0.120 |
Why?
|
Consensus | 3 | 2021 | 3124 | 0.120 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2018 | 311 | 0.120 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 276 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 29629 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2023 | 1303 | 0.110 |
Why?
|
Mutation | 7 | 2023 | 30053 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 4 | 2023 | 20568 | 0.110 |
Why?
|
Heart Failure | 3 | 2023 | 11671 | 0.110 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 1972 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 783 | 0.100 |
Why?
|
Hospitals | 2 | 2023 | 3883 | 0.100 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5841 | 0.100 |
Why?
|
Automation | 1 | 2014 | 586 | 0.100 |
Why?
|
Observer Variation | 2 | 2016 | 2606 | 0.100 |
Why?
|
Stroke Volume | 2 | 2016 | 5496 | 0.090 |
Why?
|
Sepsis | 2 | 2018 | 2585 | 0.090 |
Why?
|
Atrial Fibrillation | 2 | 2020 | 5127 | 0.090 |
Why?
|
Myocardial Contraction | 1 | 2016 | 1515 | 0.090 |
Why?
|
Educational Measurement | 1 | 2018 | 1255 | 0.090 |
Why?
|
Kidney Function Tests | 3 | 2022 | 679 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2902 | 0.090 |
Why?
|
Alleles | 1 | 2021 | 6864 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6484 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1866 | 0.090 |
Why?
|
Disease Management | 2 | 2021 | 2508 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15266 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10212 | 0.080 |
Why?
|
Propensity Score | 3 | 2024 | 1913 | 0.080 |
Why?
|
Receptors, Mineralocorticoid | 2 | 2021 | 163 | 0.080 |
Why?
|
Incidence | 7 | 2020 | 21355 | 0.080 |
Why?
|
Comorbidity | 6 | 2020 | 10508 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2019 | 2850 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3208 | 0.070 |
Why?
|
Aged, 80 and over | 11 | 2020 | 58984 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2244 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2022 | 12794 | 0.070 |
Why?
|
Fibroblasts | 1 | 2018 | 4142 | 0.070 |
Why?
|
Intensive Care Units | 3 | 2016 | 3744 | 0.070 |
Why?
|
Liver | 1 | 2023 | 7528 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4811 | 0.070 |
Why?
|
Critical Illness | 3 | 2021 | 2723 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2079 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2023 | 20100 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3964 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2022 | 39106 | 0.070 |
Why?
|
Blood Glucose | 1 | 2020 | 6391 | 0.070 |
Why?
|
Community-Acquired Infections | 1 | 2010 | 469 | 0.060 |
Why?
|
Internet | 1 | 2018 | 3093 | 0.060 |
Why?
|
Hospital Mortality | 6 | 2018 | 5293 | 0.060 |
Why?
|
Antitubercular Agents | 1 | 2014 | 1375 | 0.060 |
Why?
|
Case-Control Studies | 5 | 2024 | 22176 | 0.060 |
Why?
|
Societies, Medical | 1 | 2017 | 3905 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4725 | 0.060 |
Why?
|
Body Mass Index | 1 | 2023 | 12953 | 0.060 |
Why?
|
Biological Assay | 2 | 2018 | 626 | 0.060 |
Why?
|
Pilot Projects | 2 | 2019 | 8633 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3204 | 0.050 |
Why?
|
Abdomen | 1 | 2009 | 1128 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 698 | 0.050 |
Why?
|
Veins | 2 | 2018 | 768 | 0.050 |
Why?
|
Fibrosis | 2 | 2022 | 2049 | 0.050 |
Why?
|
Bacteremia | 1 | 2010 | 980 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10451 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3627 | 0.050 |
Why?
|
Laparoscopy | 1 | 2014 | 2036 | 0.050 |
Why?
|
MicroRNAs | 1 | 2018 | 3816 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8554 | 0.050 |
Why?
|
Lung | 1 | 2020 | 10002 | 0.050 |
Why?
|
Blood Pressure | 3 | 2024 | 8481 | 0.050 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2023 | 618 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2012 | 2091 | 0.050 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2020 | 66 | 0.050 |
Why?
|
Cytochromes c | 1 | 2021 | 173 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 2017 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2010 | 1407 | 0.050 |
Why?
|
Liver Circulation | 1 | 2020 | 159 | 0.040 |
Why?
|
Obesity | 1 | 2023 | 12947 | 0.040 |
Why?
|
Cosyntropin | 1 | 2020 | 34 | 0.040 |
Why?
|
Catheters | 1 | 2023 | 427 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2023 | 694 | 0.040 |
Why?
|
Cystatin C | 1 | 2021 | 270 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1152 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 983 | 0.040 |
Why?
|
Catheterization | 2 | 2017 | 1428 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2021 | 5247 | 0.040 |
Why?
|
Diuretics | 1 | 2022 | 610 | 0.040 |
Why?
|
Caspase 3 | 1 | 2021 | 731 | 0.040 |
Why?
|
Retreatment | 1 | 2020 | 598 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26129 | 0.040 |
Why?
|
Critical Care | 1 | 2011 | 2697 | 0.040 |
Why?
|
Cytokine Receptor gp130 | 1 | 2018 | 66 | 0.040 |
Why?
|
Thrombectomy | 1 | 2023 | 705 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 929 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 737 | 0.040 |
Why?
|
Survival Analysis | 3 | 2018 | 10090 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3578 | 0.040 |
Why?
|
Germany | 1 | 2019 | 875 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12463 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9758 | 0.040 |
Why?
|
Phlebotomy | 1 | 2018 | 137 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15843 | 0.030 |
Why?
|
Kidney | 2 | 2022 | 7048 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1188 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22174 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1039 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2024 | 15633 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 869 | 0.030 |
Why?
|
Phlebography | 1 | 2017 | 326 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3076 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 784 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 633 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 897 | 0.030 |
Why?
|
Siblings | 1 | 2019 | 825 | 0.030 |
Why?
|
Ontario | 1 | 2016 | 398 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1638 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2021 | 1989 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2217 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1787 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2122 | 0.030 |
Why?
|
Fasting | 1 | 2020 | 1603 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2023 | 2064 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22173 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1001 | 0.030 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 1007 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2397 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2139 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2280 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4111 | 0.030 |
Why?
|
Polysomnography | 1 | 2019 | 1848 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2879 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1668 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2020 | 1958 | 0.020 |
Why?
|
APACHE | 1 | 2012 | 267 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7406 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3306 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12973 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4920 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6345 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6131 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1879 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 59260 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3605 | 0.020 |
Why?
|
Potassium | 1 | 2014 | 1311 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13446 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2638 | 0.020 |
Why?
|
Population Surveillance | 1 | 2020 | 2598 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5872 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1489 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13510 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3767 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1213 | 0.020 |
Why?
|
Observation | 1 | 2009 | 310 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11076 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4812 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5429 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15601 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9647 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4244 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6597 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7828 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3415 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10554 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9542 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1186 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12059 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14608 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8225 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168475 | 0.010 |
Why?
|
Contrast Media | 1 | 2016 | 5307 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81539 | 0.010 |
Why?
|
Electrocardiography | 1 | 2016 | 6377 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18399 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9490 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18966 | 0.010 |
Why?
|
Survivors | 1 | 2012 | 2371 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9469 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 88326 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13255 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23447 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36426 | 0.010 |
Why?
|